Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Autor: De La Rubia, Javier *, Alonso, Rafael *, Clavero Sanchez, Maria Esther *, Askari, Elham *, García de Coca, Alfonso *, Maldonado, Ana *, Fernandez De La Mata, Margarita *, Escalante, Fernando *, Garcia-Feria, Ana *, Rios, Rafael *, Conesa, Venancio *, Bermudez, Maria Aranzazu *, Merchan, Beatriz *, Velasco, Alberto *, Blanchard, María Jesús *, Sampol, Antonia, Gainza González, Eukene *, Hernandez, Pedro M *, Gonzalez-Calle, Veronica *, Alegre, Adrian
Zdroj: In Blood 15 November 2022 140 Supplement 1:4315-4317
Databáze: ScienceDirect